FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis.
Medicine (Baltimore)
; 102(37): e35084, 2023 Sep 15.
Article
in En
| MEDLINE
| ID: mdl-37713871
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Microenvironment
/
Glioma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Medicine (Baltimore)
Year:
2023
Document type:
Article
Affiliation country: